(Q48748057)

15 February 2018

meta-analysis

0 references

title

Efficacy and suicidal risk for antidepressants in paediatric and adolescent patients. (English)

1 reference

15 February 2018

1 reference

Steven A Julious

1

1 reference

15 February 2018

publication date

19 January 2012

1 reference

15 February 2018

Statistical Methods in Medical Research

published in

1 reference

15 February 2018

volume

22

1 reference

15 February 2018

issue

2

1 reference

15 February 2018

page(s)

190-218

1 reference

15 February 2018

Suicidality in pediatric patients treated with antidepressant drugs

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Do antidepressants cause suicidality in children? A Bayesian meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Review of the efficacy and safety of antidepressants in youth depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

The use of antidepressants to treat depression in children and adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Antidepressants and the risk of suicidal behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Antidepressant treatment and the risk of fatal and non-fatal self harm in first episode depression: nested case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Efficacy of antidepressants in juvenile depression: meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Efficacy of sertraline in the treatment of children and adolescents with major depressive disorder: two randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Venlafaxine ER for the treatment of pediatric subjects with depression: results of two placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Reporting cumulative proportion of subjects with an adverse event based on data from multiple studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Confounding and Simpson's paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Cognitive-Behavior Therapy, Sertraline, and Their Combination for Children and Adolescents With Obsessive-Compulsive Disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Fluoxetine in children and adolescents with OCD: a placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Fluoxetine for the treatment of childhood anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

A double-blind, randomized, placebo-controlled trial of escitalopram in the treatment of pediatric depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Adolescent depression: a placebo-controlled fluoxetine treatment study and follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Fluoxetine for acute treatment of depression in children and adolescents: a placebo-controlled, randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: a placebo-controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

An international, multicenter, placebo-controlled trial of paroxetine in adolescents with major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

A multicenter, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

A randomized, double-blind, placebo-controlled study of citalopram in adolescents with major depressive disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

Clinical trial registration: a statement from the International Committee of Medical Journal Editors

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0962280211432210

21 January 2018

Identifiers

DOI

10.1177/0962280211432210

1 reference

15 February 2018

1 reference

15 February 2018